***Please note that, in order to access these course materials, you must create a user profile if you do not already have one. Your profile one ScientiaCME's website is unrelated to your profile on North American Thrombosis Forum's (NATF's) website.***
The content of this online activity was presented originally at a live event. It is divided into three videos. Learners must view both videos in their entirety and complete a post-activity assessment and evaluation before they are eligible for continuing credit.
The North American Thrombosis Forum's (NATF’s) “5th Right Heart Symposium”
The syndrome of right heart failure is poorly understood and defined. Clinicians often fail to diagnose early stages of the disease and allow the manifestations to progress to severe disability. There is a pressing need to define, understand, and inculcate awareness about this disease in clinicians. Similarly, understanding right heart dysfunction requires focused investigations and research study, best brought forth by a multidisciplinary collaboration. This program is intended for clinical and research professionals who are involved in the care of patients with, and the study of, right heart disease, congenital heart disease, pulmonary hypertension, and associated disorders.
• Nurse practitioners
• Physician assistants
• Allied healthcare professionals
In the following fields:
– Critical care medicine
– Emergency medicine
– Internal medicine
– Vascular medicine
Supported by educational grants from: Abbott Laboratories; Acceleron Pharma Inc.; Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson; and United Therapeutics.
This internet enduring material activity is part of a series of activities. Participation in this activity is free of charge.
Release Date: May 04, 2022 -- Expiration Date: May 03, 2023
Faculty: Multiple Faculty,
Pulmonary Heart Disease and Remodeling
How Does Pulmonary Disease Drive Pulmonary Vascular and Myocardial Remodeling? – Paul Hassoun, MD, Professor of Medicine, Johns Hopkins University; Director, Pulmonary Hypertension, Program Johns Hopkins Hospital
How Does Left Heart Disease Drive Pulmonary Vascular and Right Ventricular Remodeling? – Stephan Rosenkranz, MD, Professor, University of Cologne; Doctor, University of Cologne Heart Center
How Does Congenital Heart Disease Drive Pulmonary Vascular Remodeling? – Mary Mullen, MD, PhD, Assistant Professor in Pediatrics, Harvard Medical School; Associate in Cardiology, Boston Children’s Hospital
Right Heart Disease in the Absence of Pulmonary or Left Heart Disease – Michael Givertz, MD, Professor of Medicine, Harvard Medical School
Molecular Phenotyping of the Right Heart System: Is the Fog Starting to Clear? – Jane Leopold, MD, FACC, FAHA, FSCAI, Associate Professor of Medicine, Harvard Medical School; Director
Women’s Interventional Cardiology Health Initiative, Brigham and Women’s Hospital
Interventional Approaches to the Failing Right Heart
ECMO as a Bridge – Paul M. Heerdt, MD, PhD, Professor of Anesthesiology & Director of Applied Hemodynamics, Yale New Haven Hospital and Yale School of Medicine
Chromic Thromboembolic Pulmonary Hypertension: Surgical, Medical, and Interventional Options for Treatment – Piotr Sobieszczyk, MD, Instructor of Medicine, Harvard Medical School; Associate Physician, Brigham and Women’s Hospital
Percutaneous Approaches to RV Support Now and in the Future – Steven P. Keller, MD, Assistant Professor of Medicine and Biomedical Engineering, Johns Hopkins University
By the end of the session the participant will be able to:
ACCME Activity #202288293
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
Individuals with no conﬂicts of interest to disclose:
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.